Pfizer's Lyme Vaccine: What You Need to Know
Boston News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Pfizers new Lyme disease vaccine, with a below-average efficacy rate, is poised for government approval despite lower infection rates in high-risk areas. Experts believe demand will secure its place in the market, but prevention habits remain crucial as the vaccine only targets Lyme disease.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/2187b0e5e937688a